ABIVAX TO PARTICIPATE AT THE WORLD VACCINE CONGRESS

 

ABIVAX to participate at the World Vaccine Congress in Brussels (13-15 October), with a conference animated by Prof. Hartmut Ehrlich, CEO of ABIVAX, « ABIVAX case study: a novel approach to therapeutic vaccines and antivirals ».

More information: click here.

Press contacts

Caroline Carmagnol 

abivax@alizerp.com

+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65

 Standard: +33 1 53 83 08 41